Abstract

The expression and activity of insulin-like growth factors (IGFs) are increased in endometrial cancer (EC). IGFs not only mediate the positive impact of estrogen on EC, but also increase the risk for development of EC in patients with metabolic disorder. In addition, IGFs play a key role in the invasion, metastasis and drug resistance of EC. Thus, drugs that target IGFs may be the novel treatment of EC. Key words: Endometrial neoplasms; Insulin-like growth factors

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.